# Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia

> **NCT00004381** · PHASE2 · COMPLETED · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)**

## Conditions studied

- Glucosephosphate Dehydrogenase Deficiency
- Hyperbilirubinemia
- Hemolytic Disease of Newborn

## Interventions

- **DRUG:** tin mesoporphyrin

## Key facts

- **NCT ID:** NCT00004381
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004381, "Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00004381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*